| European Case Law Identifier: | ECLI:EP:BA:2000:T083897.20001114 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 14 November 2000 | ||||||||
| Case number: | T 0838/97 | ||||||||
| Application number: | 84112647.7 | ||||||||
| IPC class: | C12N 15/11 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA | ||||||||
| Applicant name: | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | ||||||||
| Opponent name: | Calgene Inc. | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | State of the art - Gordon Research Conference - public (no) - confidentiality agreement Novelty (yes) Inventive step (yes) Sufficiency of disclosure (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t970838eu1.html
Date retrieved: 17 May 2021
